healio.com
A regimen of sofosbuvir/velpatasvir with ribavirin was effective among patients with refractory chronic hepatitis C virus with liver cirrhosis and chronic kidney disease, according to data presented at The Liver Meeting.
Researchers in China investigated the safety and efficacy of a 12-week regimen of sofosbuvir/velpatasvir with ribavirin among 65 patients (mean age, 52.3 years; 77% men) with refractory chronic HCV, liver cirrhosis and chronic kidney disease (CKD). The dosage of ribavirin for ea…
about 1 year ago